Skip to main content
Veterinary Medicines

Prasequine 1 mg tablets for horses

Authorised
  • Pergolide

Product identification

Medicine name:
Prasequine 1 mg tablets for horses
Prasequine, 1 mg, tabletės arkliams
Active substance:
  • Pergolide
Target species:
  • Horse (non food-producing)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pergolide
    1.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Horse (non food-producing)
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN04BC02
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Carton box containing 13 OPA/aluminium/PVC-aluminium blisters, containing 7 tablets each
  • Carton box containing 24 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
  • Carton box containing 16 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
  • Carton box containing 10 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each
  • Carton box containing 6 OPA/aluminium/PVC-aluminium blisters, containing 10 tablets each

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/23/2738/001-005
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0368/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 4/02/2025